David Domzalski - Sep 30, 2024 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Mutya Harsch, Attorney-in-Fact
Stock symbol
VYNE
Transactions as of
Sep 30, 2024
Transactions value $
-$1,288
Form type
4
Date filed
10/2/2024, 04:15 PM
Previous filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$1.29K -685 -0.14% $1.88 497K Sep 30, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.